Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Two Different Fasting Blood Glucose Titration Targets in Glucose Control in Patients With Type 2 Diabetes Using Insulin Detemir Once Daily in Combination With 1-3 Oral Agents

NCT00634842 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT00634842
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00634842 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Two Different Fasting Blood Glucose Titration Targets in Glucose Control in Patients With Type 2 Diabetes Using Insulin Detemir Once Daily in Combination With 1-3 Oral Agents
Lead sponsor
Novo Nordisk A/S
Phase
Phase 4
Overall status
Completed
Start date
February 29, 2008
Completion date
October 31, 2008
Enrollment
244 (actual)
Sites
69

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, diabetes mellitus, type 2